[ad_1] Nucleix received funding from Lung EpiCheck, a screening blood test for the early detection of lung cancer. Nucleix, the Israeli cancer detection and detection company, announced today that it has received …
Read More »Cancer Screening Company Nucleix Raises 2.5 Million Euros
[ad_1] Israel-based Nucleix Ltd. has received 2.5 million euros in funding from Horizon 2020, the European Union's research and innovation program, to develop its blood-based lung cancer early detection test, the company …
Read More »